Drug Shortage Report for PROPOFOL
Report ID | 103474 |
Drug Identification Number | 02468336 |
Brand name | PROPOFOL |
Common or Proper name | PROPOFOL |
Company Name | BAXTER CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PROPOFOL |
Strength(s) | 10MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS |
Packaging size | 20mL Vials |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-01-17 |
Actual start date | 2020-01-17 |
Estimated end date | 2020-02-11 |
Actual end date | 2020-02-11 |
Shortage status | Resolved |
Updated date | 2020-02-12 |
Company comments | Customers can choose the alternate format of Propofol 50mL Vials or 100mL Vials if it fits their clinical needs. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-17 | English | Compare |
v2 | 2020-01-17 | French | Compare |
v3 | 2020-01-18 | English | Compare |
v4 | 2020-02-10 | English | Compare |
v5 | 2020-02-10 | French | Compare |
v6 | 2020-02-11 | English | Compare |
v7 | 2020-02-11 | French | Compare |
v8 | 2020-02-12 | English | Compare |
Showing 1 to 8 of 8